期刊文献+

pEGFP-N1-TNFα表达载体的构建与鉴定 被引量:1

Construction and identification of pEGFP-N1-TNFα expression vector
下载PDF
导出
摘要 目的构建pEGFP-N1-TNFα重组质粒并鉴定,为转导CIK细胞并定位表达奠定基础。方法以pMD19Sim-ple T-TNFα为模板,PCR扩增TNFαCDS区片段,将PCR产物进行15g/L琼脂糖凝胶电泳,并回收TNFα条带,用BglⅡ和HindⅢ将TNFα的PCR片段及目的载体pEGFP-N1双酶切,然后进行连接。连接产物转化至DH5α中。挑取克隆,提质粒,进行鉴定。结果 PCR扩增片段、双酶切出现722bp大小的目的基因条带与预期结果相符;插入片断测序结果与合成的寡核苷酸序列一致。结论成功构建了重组质粒pEGFP-N1-TNFα,为下一步用纳米材料转染CIK细胞的研究奠定了基础。 Objective To construct and indentify a recombinant pEGFP-N1-TNFa expression plasmid so as to lay a foundation for transfecting CIK cells and localize the expression. Methods pMD19 Simple T-TNFa was taken as template, the fragment Supported by the Technological Plan of Social Development of Yunnan Province (Fundamental Research Program, No. 2009ZCllgM), the Health and Science Research Institutes Foundation of Yunnan Province (No. 2011WS0068), and the Technological Plan of Social Development of Yunnan Province (Key Fundamental Research Program, No. 2009CC026) of CDS region of TNFe was amplified by PCR, and then the products of PCR amplification underwent agarose gel electrophoresis. The fragment TNF was excised, and then fragment TNFa and aimed vector were excised by Bgl H and Hind m double digestion. The excised products were connected; the product was then transformed into DH5a. The positive clones were selected, from which plasmid DNA was abstracted and identified by sequencing. Results The size of PCR products and double digested section were 722 bp, which was in accordance with the expected results; sequence analysis of inserted fragment revealed the same sequence as synthesize oligonucleotides. Gorlclusion The pEGFP-NI-TNF expression vector had been successfully constructed, which laid a foundation for future study on nanomaterial-mediated transfection into CIK cells.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第2期263-266,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 云南省社会发展科技计划(应用基础研究项目 No.2009ZC119M) 云南省社会发展科技计划(应用基础研究重点项目 No.2009CC026) 云南省卫生科技内设研究机构资助项目(No.2011WS0068)
关键词 肿瘤坏死因子 真核表达载体 质粒pEGFP—N1 基因疗法 CIK细胞 tumor necrosis factor (TNF) eukaryocyte expression vector pEGFP-N1 plasmid gene therapy CIK cell
  • 相关文献

参考文献9

二级参考文献98

  • 1郭伟,何荣根,邱蔚六,张志愿.舌鳞癌引流区淋巴结细胞联合平阳霉素的抑瘤作用[J].上海口腔医学,1992,1(1):40-42. 被引量:2
  • 2郭伟,邱蔚六,何荣根.口腔癌引流区淋巴结细胞对人舌鳞癌细胞的杀伤机理[J].中华口腔医学杂志,1995,30(3):143-145. 被引量:8
  • 3杨志英,余平.BH3-only蛋白的研究进展[J].医学临床研究,2006,23(5):801-803. 被引量:4
  • 4Yu P, Fu YX. Tumor-infiltrating T lymphocytes: Friends or foes [J]. Lab Invest, 2006, 86(3):231-245.
  • 5Younes A, Kadin ME. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy[J]. J Clin Oncol, 2003, 21 (18) :3526-3534.
  • 6Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes[J]. Science, 2006, 314(5796):126-129.
  • 7Rosenberg SA. Gene therapy for cancer[J]. JAMA, 1992, 268 (17): 2416-2419.
  • 8Aoki Y, Takakuwa K, Kodama S, et al. Use of adoptive transfer of tumor-infihrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer[J]. Cancer Res, 1991, 51(7):1934-1939.
  • 9Skornick Y, Topalian S, Rosenberg SA. Comparative studies of the long-term growth of lymphocytes from tumor infiltrates, tumor-draining lymph nodes, and peripheral blood by repeated in vitro stimulation with autologous tumor[J]. J Biol Response Mod, 1990, 9(4) :431-438.
  • 10Uren R T, Dewson G, Chen L, et al. Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol, 2007, 177(2): 277-287.

共引文献49

同被引文献20

  • 1Schmidt RE,Murray C,Daley JF. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype[J].Journal of Experimental Medicine,1986,(1):351-356.
  • 2Kim YJ,Lim J,Kang JS. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells[J].Archives of Pharmacal Research,2010,(11):1789-1795.
  • 3Cui Y,Yang X,Zhu W. Immune response,clinical outcome and safety of dendritic cell vaccine in combination with cytokineinduced killer cell therapy in cancer patients[J].Oncol Lett,2013,(2):537-541.
  • 4Philip R,Epstein LB. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself,gamma interferon and interleukin-1[J].NATURE,1986,(6083):86-89.
  • 5Ha Thi HT,Lim HS,Kim J. Transcriptional and post-translational regulation of Bim is essential for TGF-β and TNF-α-induced apoptosis of gastric cancer cell[J].Biochimica et Biophysica Acta,2013,(6):3584-3592.
  • 6Chu WM. Tumor necrosis factor[J].CANCER LETTERS,2013,(2):222225.
  • 7Liu F,Huang L. Development of non-viral vectors for systemic gene delivery[J].Journal of Controlled Release,2002,(1-3):259-266.doi:10.1016/S0168-3659(01)00494-1.
  • 8Chan CK,Senden T,Jans DA. Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines[J].Gene Therapy,2010,(19):1690-1697.
  • 9Prabha S,Zhou WZ,Panyam J. Size-dependency of nanoparticle-mediated gene transfection:studies with fractionated nanoparticles[J].International Journal of Pharmaceutics,2002,(1 2):105-115.doi:10.1016/S0378-5173(02)00315-0.
  • 10Tang MX,Redemann CT,Szoka FC Jr. In vitro gene delivery by degraded polyamidoamine dendrimers[J].Bioconjugate Chemistry,2006,(6):703-714.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部